MedTrace Logo

Maestro Agreement and Precision Study II

NCT02376868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2022-06-08

No results posted yet for this study

Summary

Assess the repeatability and agreement of the Optic Disc Parameters, Retinal Nerve Fiber Layer (RNFL) Thickness, Full Retinal Thickness, and Ganglion Cell Thickness between the Maestro and iVue OCT devices.

Conditions

  • Normal Healthy Subjects With No Known Ocular Diseases
  • Glaucomatous Eyes
  • Eyes With Retinal Diseases

Interventions

DEVICE

3D OCT-1 Maestro

OCT machines used for diagnostic purposes

DEVICE

iVue

OCT machines used for diagnostic purposes

Sponsors & Collaborators

  • Topcon Medical Systems, Inc.

    lead INDUSTRY

Principal Investigators

  • Charles Reisman, MS · Topcon Corporation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02376868 on ClinicalTrials.gov